Brief: Viva Biotech Holdings Posts HY Net Loss Of RMB 530.3 Mln
31/08/2020 14:58
Aug 31 (Reuters) - VIVA Biotech Holdings 1873.HK :
* RESOLVED TO DECLARE INTERIM DIVIDEND OF HK$0.017 PER SHARE
* HY NET LOSS RMB530.3 MILLION VERSUS PROFIT OF RMB46.5
MILLION
* HY REVENUE RMB197.6 MILLION VERSUS RMB142.3 MILLION
* SPEEDING UP CONSTRUCTION OF A ONE-STOP DRUG SERVICE
PLATFORM
Source text for Eikon: ID:nHKShZkb9
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical